Do all documents need to be signed in one color? Does the FDA not accept review by exception? What is real and what is a myth when it comes to FDA regulations for pharmaceutical manufacturing?

In our first episode of PEP talks, we’ll clear up some myths and misinterpretations of regulatory requirements with our expert guest Daniel R. Matlis, President and Founder of Axendia, Inc. You won’t want to miss this discussion as commonly held beliefs get busted.

📌 For more information about PEP talks, please visit our website.

📌 Make sure to subscribe to our Newsletter and Körber Pharma LinkedIn channel to stay up to date on current episodes.